The millions of children coping with attention deficit/hyperactivity disorder (ADHD) have many more treatment options now than they did even 10 years ago. New drugs and newer, longer-lasting formulations of older drugs have given prescribers and patients more to choose from. Improved choice may also mean improved compliance.
